{"id":"NCT04873934","sponsor":"Novartis Pharmaceuticals","briefTitle":"Management of LDL-cholesterol With Inclisiran + Usual Care Compared to Usual Care Alone in Participants With a Recent Acute Coronary Syndrome","officialTitle":"A Randomized, Controlled, Multicenter, Open-label Trial Comparing a Hospital Post-discharge Care Pathway Involving Aggressive LDL-C Management That Includes Inclisiran With Usual Care Versus Usual Care Alone in Patients With a Recent Acute Coronary Syndrome (VICTORION-INCEPTION)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-06-24","primaryCompletion":"2024-08-07","completion":"2024-08-07","firstPosted":"2021-05-05","resultsPosted":"2025-08-21","lastUpdate":"2025-08-21"},"enrollment":400,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Acute Coronary Syndrome"],"interventions":[{"type":"DRUG","name":"Inclisiran","otherNames":["KJX839"]}],"arms":[{"label":"Inclisiran with Usual Care","type":"EXPERIMENTAL"},{"label":"Usual Care","type":"NO_INTERVENTION"}],"summary":"The purpose of this study is to study the effectiveness of implementation of a systematic LDL-C management pathway including treatment with inclisiran in participants who have experienced a recent acute coronary syndrome (ACS) and have an increased LDL-cholesterol (â‰¥70 mg/dL) despite being treated with a statin drug.","primaryOutcome":{"measure":"Percent Change From Baseline to Day 330 in LDL-C","timeFrame":"Baseline and Day 330","effectByArm":[{"arm":"Inclisiran With Usual Care","deltaMin":-45.6,"sd":null},{"arm":"Usual Care","deltaMin":1.4,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":88,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":32,"n":203},"commonTop":["COVID-19","Non-cardiac chest pain","Upper respiratory tract infection","Dizziness","Blood creatine phosphokinase increased"]}}